Literature DB >> 15370105

Neutrophils in the gray platelet syndrome.

James G White1, Richard D Brunning.   

Abstract

A recent report of three siblings with the gray platelet syndrome (GPS) and two others, a brother and sister, has indicated that patients with the GPS have gray neutrophils, as well as gray platelets. Their neutrophils are markedly deficient in secondary granules and vesicles and the empty cytoplasm appears gray on peripheral blood smears. We have evaluated five patients with the GPS, including the original case described by Raccuglia (Am J Med 1971; 51: 818-28). The results indicate that GPS neutrophils have normal secondary granules, and they are not gray on peripheral blood smears or in thin sections. The patients described in the recent report by the French workers appear to have a familial hypogranular neutrophil and platelet disorder, but it does not appear to be the GPS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370105     DOI: 10.1080/09537100410001714872

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  4 in total

1.  Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.

Authors:  Meral Gunay-Aygun; Yifat Zivony-Elboum; Fatma Gumruk; Dan Geiger; Mualla Cetin; Morad Khayat; Robert Kleta; Nehama Kfir; Yair Anikster; Judith Chezar; Mauricio Arcos-Burgos; Adel Shalata; Horia Stanescu; Joseph Manaster; Mutlu Arat; Hailey Edwards; Andrew S Freiberg; P Suzanne Hart; Lauren C Riney; Katherine Patzel; Pranoot Tanpaiboon; Tom Markello; Marjan Huizing; Irina Maric; McDonald Horne; Beate E Kehrel; Kerstin Jurk; Nancy F Hansen; Praveen F Cherukuri; Marypat Jones; Pedro Cruz; Jim C Mullikin; Alan Nurden; James G White; William A Gahl; Tzippora Falik-Zaccai
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

2.  Neutrophil specific granule and NETosis defects in gray platelet syndrome.

Authors:  Cathelijn E M Aarts; Kate Downes; Arie J Hoogendijk; Evelien G G Sprenkeler; Roel P Gazendam; Rémi Favier; Marie Favier; Anton T J Tool; John L van Hamme; Myrto A Kostadima; Kate Waller; Barbara Zieger; Maaike G J M van Bergen; Saskia M C Langemeijer; Bert A van der Reijden; Hans Janssen; Timo K van den Berg; Robin van Bruggen; Alexander B Meijer; Willem H Ouwehand; Taco W Kuijpers
Journal:  Blood Adv       Date:  2021-01-26

3.  NBEAL2 is required for neutrophil and NK cell function and pathogen defense.

Authors:  John M Sowerby; David C Thomas; Simon Clare; Marion Espéli; Jose A Guerrero; Kim Hoenderdos; Katherine Harcourt; Morgan Marsden; Juneid Abdul-Karim; Mathew Clement; Robin Antrobus; Yagnesh Umrania; Philippa R Barton; Shaun M Flint; Jatinder K Juss; Alison M Condliffe; Paul A Lyons; Ian R Humphreys; Edwin R Chilvers; Willem H Ouwehand; Gordon Dougan; Kenneth Gc Smith
Journal:  J Clin Invest       Date:  2017-08-07       Impact factor: 14.808

4.  Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.

Authors:  Matthew C Sims; Louisa Mayer; Janine H Collins; Tadbir K Bariana; Karyn Megy; Cecile Lavenu-Bombled; Denis Seyres; Laxmikanth Kollipara; Frances S Burden; Daniel Greene; Dave Lee; Antonio Rodriguez-Romera; Marie-Christine Alessi; William J Astle; Wadie F Bahou; Loredana Bury; Elizabeth Chalmers; Rachael Da Silva; Erica De Candia; Sri V V Deevi; Samantha Farrow; Keith Gomez; Luigi Grassi; Andreas Greinacher; Paolo Gresele; Dan Hart; Marie-Françoise Hurtaud; Anne M Kelly; Ron Kerr; Sandra Le Quellec; Thierry Leblanc; Eva B Leinøe; Rutendo Mapeta; Harriet McKinney; Alan D Michelson; Sara Morais; Diane Nugent; Sofia Papadia; Soo J Park; John Pasi; Gian Marco Podda; Man-Chiu Poon; Rachel Reed; Mallika Sekhar; Hanna Shalev; Suthesh Sivapalaratnam; Orna Steinberg-Shemer; Jonathan C Stephens; Robert C Tait; Ernest Turro; John K M Wu; Barbara Zieger; Taco W Kuijpers; Anthony D Whetton; Albert Sickmann; Kathleen Freson; Kate Downes; Wendy N Erber; Mattia Frontini; Paquita Nurden; Willem H Ouwehand; Remi Favier; Jose A Guerrero
Journal:  Blood       Date:  2020-10-22       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.